Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
only 1 3 or 1 8 rs is allowed, thats all the sh voted for previously. no other ratios allowed
They can only RS 1 3 or 1 8 thats all the sh voted for last time
Upcoming R/S 1 for 8
approved plans are 1 for 3 or 1 for 8, they wont bother with 1 for 3 have to go 8.
JULY Proposal 2: This proposal was not approved by the stockholders, with 54,209,769 “AGAINST” votes, 52,402,503 “FOR” votes and10,063,123 “ABSTAIN” votes. There were no broker non-votes.
Now enter Dr Soon and his shares PROMISED to vote for any board recommendations.
Here is the new vote upcoming this month
54,209,769 “AGAINST” votes, 64,402,503 “FOR” votes and 10,063,123 “ABSTAIN” votes.
R/S is a shoe in.
ALSO, remember, those that sold off and left, they are the ones that get to vote, those new owners, they dont get to vote. The ones that left probably wont vote, so the FORS will be LESS and the ABSTAIN will be higher. Win by attrition
This was THEIR PLAN
Company at a low is worth 23 cents a share so 1 for 8 gets you $1.84 with about a 21.4 million issued and 19.15m float for a 40 million mkt cap, where it was historically dec 2016.
Could be 45 prior to split but i see a lot lower, at 45 it opens at $3.60 post split and drops that morning t0 $2.10 then sinks that week to $1.84
Just go look at ANTH, this is the same crap stock scenario.
Be warned, current BOOK SHARE is only 14 pennies, in theory, this could EASILY sink to $1.12 OR EVEN LESS IMMEDIATELY after market opens post split.
Seeing the resulting devalue post split many will simply BAIL and this stock has been so overplayed new buyers arent coming into a post split devalued mess where the lead drug has been licensed off.
I see a train wreck Monday 930 once those robin hooders can trade, massive sell off and stops kick in. BLOOD
SOON WINS NO MATTER WHAT
CytRx has also issued NantCell a warrant to purchase up to 3 million shares of common stock, also at $1.10, over the next year and a half.
After a split he makes back ALL OF HIS 13 MILLION INVESTMENT, he gets the post split stock at 1.10
I tried to warn people in July, but they ARE ALL SO MUCH SMARTER THAN THE ENTIRE STOCK MARKET
BS BUDDY, Its public record that SOON MUST VOTE WITH THE BOARD for the shares he bought. THATS THE REASON FOR THE DEAL, TO GET R/S PASSED.
Plenty of news articles out there corroborate these FACTS with regards to soons shares of cytr.
R/S is APPROVED
That why they brought in SOON
He bought JUST ENOUGH shares and had to sign a PROMISE TO VOTE WITH THE BOARD.
The R/S is all but done the only thing we dont know is the ratio. That will be decided by the board based on prior approvals at prior votes.
I did the math on the all time low and market cap, dec 2016, and the shares today, it is 23 pennies per share at current approved shares.
Keep in mind this company has NOT filed an NDA and they have now sold that to SOON. So if he never files the NDA not their problem.
You should read up on SOON, not good, lots of bad there. Legal investigations underway.
When robin hood opens on monday, this goes to 10 pennies. 10 to 15 million shares in the first minute.
Whats the upside ?
100 patients in europe at 250k per procedure, which is also all costs, dr, hospital etc. Of that dcth got a fraction.
10k cases in usa per year, thats 3/4 of a billion GROSS for the procedure, so whats the upside for dcth ?
Not a lot.
And its under threat of any new treatment that is better in class.
Terrible long investment
New bag holders should be offered some kind of welcome kit. Theres a bunch of them today, the final baggers I think.
What kind of things should be in their goody bag ?
FMV is 2.6 pennies for this stock by the way.
No matter how you slice it, the historic pricing and market cap high lows prior to jan 1 2017 don't lie.
Do the math, its 2.6 pennies per share today.
100 procedures in Germany at 250k each and delcath got very little of that. There is going to have to be a MASSIVE OUTBREAK of liver cancer in the usa to ever support this being worth what the bulls claim for this stock. Add to that we have emerging cures, dozens of them in the pipeline, that threaten this.
A terrible long, good day play though :)
But its dead after this run, reverse split is done deal, they have the votes now.
KUDOS...
To the person that bought 7 million shares at under 8 cents then bought 50 thousand dollars worth last night in multiple buys to 24 cents then sold all for 21 plus cents this morning.
Nice way to work it just before the R/S that is GOING through now that they have the votes.
You sir are a master.
Pos E/R Estimated
PT 7 to 10
Analysts expect pSivida Corp. (NASDAQ:PSDV) to report $-0.14 EPS on September, 11.They anticipate $0.05 EPS change or 26.32% from last quarter’s $-0.19 EPS. After having $-0.15 EPS previously, pSivida Corp.’s analysts see -6.67% EPS growth. The stock decreased 1.85% or $0.02 during the last trading session, reaching $1.06. About shares traded. pSivida Corp. (NASDAQ:PSDV) has declined 20.28% since August 18, 2016 and is downtrending. It has underperformed by 36.98% the S&P500.
Among 5 analysts covering pSivida (NASDAQ:PSDV), 5 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. pSivida had 9 analyst reports since October 15, 2015 according to SRatingsIntel. On Tuesday, June 13 the stock rating was maintained by FBR Capital with “Buy”. The stock has “Buy” rating by H.C. Wainwright on Friday, June 23. The stock of pSivida Corp. (NASDAQ:PSDV) earned “Buy” rating by Ladenburg on Tuesday, June 13. On Thursday, October 15 the stock rating was initiated by FBR Capital with “Outperform”. The firm earned “Buy” rating on Tuesday, July 11 by H.C. Wainwright. The firm has “Buy” rating given on Wednesday, June 14 by H.C. Wainwright. H.C. Wainwright maintained the stock with “Buy” rating in Tuesday, May 30 report. The stock of pSivida Corp. (NASDAQ:PSDV) has “Buy” rating given on Wednesday, June 14 by Northland Capital.
HUGE UPSIDE
https://seekingalpha.com/article/4081927-psividas-recent-trial-results-still-stellar-despite-downward-movement
https://seekingalpha.com/article/4087800-psivida-spec-biotech-major-buy-signals
https://seekingalpha.com/article/4080261-psivida-undervalued-final-phase-iii-durasert-data-imminent
https://seekingalpha.com/article/4074119-eye-ophthalmology-analyzing-psividas-upcoming-clinical-trial
UP 16% A/H GOING TO ROCKET
Get on board this is going to be THE STOCK to own of 2017.
Depressed by POORLY WORDED PHASE 3 RESULTS, people read into them that IT CAUSES CATARACTS LOL, and sold off.
NO, it does NOT cause cataracts, the company is FINANCIALLY CONSERVATIVE, is going for an NDA on a WINNER DRUG to prevent blindness, and is about to post GREAT ER.
Rated a buy at 7 to 10 bucks and is lowest ever right now and up 16 percent overnight.
Climb aboard and hold this one is a WINNER.
RUN AWAY HEADED TO PENNY LOWS
This same filing was done Summer of 2016 when stock was at 60 cents and we ended up at 18 cent lows cause stock went from 28m shares to almost 40m shares when this SAME FILING was done for those warrants back then followed weeks later by a massive 12 million offering to fund phase 2.
That where we are today same filing releasing tons of shares to the float AND a possible 15 to 20 million dollar offering on the horizon to fund p3.
float will go from 70 million to approaching 200 million once these warrants and a massive offering are done.
Its gonna be a portfolio killer for a year or more, will see mid single digits or even LESS, very soon.
Was 60 cents last time and went to 18 now under 30 cents and rinse repeat and MUCH LARGER OFFERING looming, RUN AWAY
IF UAMA PATENT does not SPECIFICALLY STATE SERVER SIDE, their patent is dead, means they INFER server and client side. INFER is BS in court. SC patent STATES server side, for SC to infringe on UAMA, then the UAMA patent MUST state SERVER SIDE and the UAMA patent must predate the NOBLI patent SC bought out
https://techcrunch.com/2017/04/20/snap-acquires-the-crucial-geofilter-patent-from-mobli-for-a-record-7-7m/
Patent may be no good
Need to read the uama patent and compere to the MOBLI patent that SC bought out. Look for SERVER SIDE language in either and also look at patent dates, UAMA was jan 4 2014, if MOBLI predates that then MOBLI and SC win in court and UAMA's issue will be with the patent office, dead, no money
RUN FROM THIS FAST ?
"Possible Upcoming Catalysts"
OR
"Why I am not buying this stock"
Lacking a partner this company may need a LOT OF MONEY for phase 3 testing and general operations. This company is most likely more than 12 months away from any new commercial product offering and income..
1- Stock will set a new low of 0.152 between now and market close Friday Sept 1
2- Reverse split 1 for 25 could be announced Friday Sept 1 AH effective Monday Sept 4 PM.
3- Stock may stabilize Monday the 4'th at 4 dollars (16 cents pre split).
4- Within 10 days Rosacea topline data may be announced resulting in stock climbing to record high of 8 dollars (actually only 32 cents pre split)
5- A few days later 25 million dollar offering may be announced priced at 7 dollars a share, stock will recede to 7 dollars, higher than post split opening weeks before but only 28 cents pre split.
SIGNS
Stock was increased from 90k to 450k shares by board in 2017, that authorization DOES NOT REVERSE SPLIT. That authorization STANDS in the wings for future sales and dilution of the retail shares.
Why offer 20 to 25 million at 15 to 30 cents and use up all your authorized stock inventory when you can reverse split and get the same amount of cash using A LOT LESS STOCK INVENTORY and also MAKE YOUR COMPANY listing compliant.
All signs may point to r/s, news release, major offering, dilution. The recent highly discounted tiny offering that crashed the stock to hi 20's is more evidence of the future.
Those entered at 50 cents pre split would need to wait for 12.50 stock price to break even.
A r/s almost ensures that any dream of major returns are dashed and replaced with hopes to get out even or with less loss at some future date.
2 FAILED P3, SO NDA FILED LOL
Thats right , TWO failed P3 on the SAME drug, then when this other drug tanks their stock, they filed a NDA on the one that has 2 failed P3's.
COME ON PEOPLE, this is going south big time.
RUN
Adam Feuerstein
One tweet from AF on this mess and I would NOT want to be holding this stock, will go to 50 cents in seconds. The NDA filing is an obvious CYTR LIKE ruse that is just being used to forestall the inevitable sp decline. You notice CYTR still has NOT filed that NDA, im guessing never will, why waste the $$$, they know,,,,
G E T O U T N O W
Holy zipline to zero batman, these guys are using the CYTR playbook on steroids. Aside from all the spying cloak and dagger drama, they have done the hail mary go for NDA on a failed p3 drug, just to keep the company above a dollar and floating along while they try to figure out what to do with an empty failed pipeline.
The fda must be shaking their head as cytr and now these clowns file for NDA's on proven failed candidates and the FDA says sure u can FILE, any idiot can FILE, approval ? thats a different thing altogether.
This explains why the codename for the failed takeover plot by the ex ceo was PROJECT RESCUE as he supposedly tried to take the license for their drug from them and move it to a shell company he and others would control, this per the pr from the aezs board.
LOOKS LIKE P&D ?
https://seekingalpha.com/article/312267-genesis-biopharma-managements-troubled-history-of-failed-companies-and-stock-promotion-portends-future-shareholder-pain
http://mjinews.com/oxis-reverse-stock-split-case-study/
http://www.thechairmansblog.com/company_executives/anthony-cataldo/
Googled pure spectrum investor...
https://en.wiktionary.org/wiki/there%27s_a_sucker_born_every_minute#English
LOL OBVIOUS SCAM EVIDENCE
So.. they announce they SECURED THEIR OLD DOMAIN
which never existed until it was created on july 18 2017 per ICANN
SO RIDDLE ME THIS BATMAN
With this MEGA MERGER coming, why didnt they pay the extra money and SECURE THE DOMAIN FOR THIS MEGA OFFERING FOR MORE THAN A YEAR ?
They could have bought up to 10 years.
Maybe they dont expect to be here in a year ?
Updated Date: 2017-07-18
Created Date: 2017-07-18
Registration Expiration Date: 2018-07-18
WE SECURED OUR DOMAIN
sounds like someone else had it, they went to great lengths to get it...
OR...
it never existed cause no one wanted that name until they created it on july 18 2017, TODAY
which is the ACTUAL FACT
https://whois.icann.org/en/lookup?name=purespectruminc.com%20
Nobody ever went broke underestimating the intelligence of the gen pop investor
THE RUN IS OVER U MISSED IT
BUY THIS BAILOUT OTHERS
AND MORE
http://adserv.stocksite.com/images/pubdocs/mmg/Florida_Final_Judgment_iHub_v_REDACTED.pdf
(replace REDACTED with "m i n a m a r" ...no spaces or quotes )
http://www.octafinance.com/why-emry-capital-group-inc-just-disclosed-huge-new-trimax-corp-stake/
https://fintel.io/i/emry-capital-group
http://emrycapital.com/
READ READ READ
http://ihwiki.advfn.com/index.php?title=MMG_Injunction
REDACTED is involved in this
http://www.otcmarkets.com/ajax/showFinancialReportById.pdf?id=140626
per google search
REDACTED@gmail.com is owned by REDACTED (Trimax Corp)
per google search also owns these
technologylawsuits.com 2012-12-07 alpinedomains.com
m-vite.com 2013-04-03 domain.com
sukodo.com 2015-01-08 alpinedomains.com
namekeys.com 2012-11-01 godaddy.com
matchdirectory.com 2012-12-07 namebright.com
eldoradohillshousesforsale.com 2012-11-02 wildwestdomains.com
spartanburghousesforsale.com 2012-11-02 wildwestdomains.com
daveandpatty.com 2016-06-20 enom.com
colorsofroses.com 2012-11-02 godaddy.com
sanfordhousesforsale.com 2012-11-02 wildwestdomains.com
rivalle.com 2012-12-08 alpinedomains.com
fyim.com 2012-11-02 godaddy.com
homesforsalemacon.com 2012-11-02 wildwestdomains.com
ranchohomesforsale.com 2012-11-02 wildwestdomains.com
officexpress.net 2012-11-02 godaddy.com
corporatemind.com 2012-11-02 godaddy.com
homesforsaleshakopee.com 2012-11-02 godaddy.com
bozemanhousesforsale.com 2012-11-02 godaddy.com
sticktunes.com 2012-11-03 godaddy.com
refuelit.com 2017-01-07 namebright.com
accelerationfactor.com 2012-11-03 wildwestdomains.com
degussachem.com 2013-03-13 ascio.com
cockrings.info 2013-12-25 enom.com
best-of-the-city.com 2014-10-05 enom.com
parfumehouse.com 2017-06-10 name.com
weekendinaustralia.com 2017-02-09 tppwholesale.com.au
e-banks.com 1999-09-29 enom.com
pitchcompetition.com 2012-12-09 namebright.com
newrochellebroker.com 2012-11-05 godaddy.com
romve.com 2012-11-05 godaddy.com
preferredautodealer.com 2012-11-04 godaddy.com
spicestream.com 2012-12-13 namebright.com
celebritystash.com 2003-11-07 gkg.net
cosmeticdentist-pa.com 2015-04-24 register.com
brothelsonline.com 2013-01-04 namebright.com
emiliechandler.com 2000-06-27 enom.com
dfwrealestateforsale.com 2012-11-10 wildwestdomains.com
wapden.com 2012-11-05 godaddy.com
lifeactionministries.com 1999-10-07 enom.com
professionalwebsites.info 2013-01-13 enom, inc
cruise-africa.com 2012-11-13 godaddy.com
dermablendreviews.com 2012-11-05 godaddy.com
gamblia.com 2012-11-12 godaddy.com
frenchspa.com 2012-11-12 godaddy.com
mustardpieclothing.com 2009-02-08 enom.com
foodgateway.com 2012-12-10 namebright.com
7issues.us 2016-10-31 (registration services) whois.dynadot.com
hollywoodhelpline.com 2012-12-11 namebright.com
nursevisits.com 2010-11-10 namebright.com
superhealthysnack.com 2012-11-04 wildwestdomains.com
chelseaandtaylor.com 2017-01-08 enom.com
ausblow.com 2013-09-03 enom.com
mytravelmanager.com 2012-11-08 godaddy.com
benningfashion.com 2016-08-15 enom.com
micropolls.com 2012-11-08 godaddy.com
merci-moments.com 2016-07-04 key-systems gmbh
catherineandpatrick.com 2016-11-18 enom.com
meganto.com 2012-11-10 godaddy.com
uslogisticsllc.com 2013-01-11 register.com
prodmanagement.com 2013-01-17 namebright.com
thegreatislam.com 2012-11-13 wildwestdomains.com
taylorandgrant.com 2016-04-17 enom.com
infographicblog.com 2012-11-13 godaddy.com
fixmycreditcards.com 2015-03-05 directnic.com
hotel-cheaper.com 2012-11-07 godaddy.com
whypeoplesnore.com 2012-11-11 godaddy.com
lateshows.com 2012-11-13 godaddy.com
tekscribe.com 2012-11-09 godaddy.com
revivalnetwork.net 2002-05-09 enom.com
hotelsinmanhattan.net 2012-11-09 godaddy.com
benignhypertension.com 2012-11-07 godaddy.com
guccibelts.info 2016-11-03 1api gmbh
artsconsultants.com 2012-12-17 namebright.com
venturehost.com 2012-12-15 namebright.com
homesincda.com 2012-11-06 wildwestdomains.com
buildfolio.com 1999-09-23 namebright.com
ryanandtara.com 2016-02-22 enom.com
ppkerstars.net 2017-05-09 dynadot.com
foosballclub.com 2012-12-20 namebright.com
voiphospitality.com 2012-11-08 godaddy.com
dealfile.com 2012-12-17 namebright.com
ultrafood.com 2003-10-16 name.com
writerscafe.us 2016-10-31 (registration services) whois.dynadot.com
personalizedmarketplace.com 2012-11-07 godaddy.com
flowerstousa.com 2012-11-10 godaddy.com
tsimay.com 2009-09-28 enom.com
fcocondo.com 2014-12-19 enom.com
highlandweather.com 2016-08-11 1api.net
equestriantrailguide.com 2015-10-12 enom.com
voaric.com 2016-04-11 publicdomainregistry.com
canameds.com 2012-12-12 rebel.com
gonnacam.com 2012-11-13 godaddy.com
buyinmass.com 2012-11-14 godaddy.com
tosliquid.com 2012-09-02 markmonitor.com
mortgageranking.com 2012-11-15 godaddy.com
greensnakes.com 2012-11-09 godaddy.com
australiapassport.com 2012-12-15 namebright.com
businesscapitalconsultants.com 2013-12-20 register.com
computersurvey.net 2012-12-14 namebright.com
pizzapolis.com 2012-12-09 alpinedomains.com
I never short...
RE: VDRM patent pending and other patent holders of somewhat similar appearing ip like fomx bpmx
The patent office SCREENING and accepting an application provides ZERO confidence that the patent application does not infringe on an existing patent, that confidence comes from (A) an approved patent (B) prevailing in any future infringement cases. This company lacks (A).
Their application is so new that any patent holders out there probably have had zero time to form a legal challenge, and don't HAVE TO until they want to, Like AFTER these guys go to market.
With regards to the current patent lawsuit, totally frivolous, VDRM's previous patent attorney filed for a patent, the patent office replied back and they never got a response back, The application DIED. Then VDRM applies, and he comes out of the woodwork claiming ownership via his application prior to this.
Sorry, his claim DIED with his failure to REPLY to USPTO, people make BIG BUSINESS REAPPLYING other peoples filings with USPTO when THEY fail to reply and their submissions die.
His suit has no legs.
None of this implies they are infringing, but anyone going long in any bio that has fda and patent requirements needs to have the i's dotted and t's crossed at ALL TIMES, this company has the cart before the horse for me.
Flipping is fine but...
Going long ?
I have read a lot here and dont really care about much of what I found, the lawsuit patent issue not a concern, the original filer failed to respond to uspto so they lost their patent, suit is frivolous.
Issues about a dirty lab that no one can tie to the produced product, to which the company supposedly has stated to someone they did not use, not a concern either.
HERE IS MY REAL CONCERN
Supposedly going forward to sales with a PENDING PATENT ?
REDFLAG, go research HEAVILY the science and tech behind FOMX and BPMX (BPX-01)
FOMX has a patent on a through the skin delivery system that is NOT water based, it performed poorly in P3.
BPMX has a patent on a NON OIL based delivery system that is entering P3 shortly, for which they HAVE a patent.
As I look at the disclosed science provided thus far from VDRM regarding their 90% effective non oil based delivery system, huge red flag goes up. H U G E.
I wouldnt go long for 0.0001 on this company until I SEE a patent issued and frankly that should have occurred LONG AGO in this process.
BPMX plans to develop NUMEROUS drug delivery products using their PATENTED NON OIL BASED DELIVERY VEHICLE.
If this PENDING patent from VDRM is found to infringe on anothers patents, this companies pipeline based on that non oil based vehicle is ZERO.
Not saying they are the same, but no patent, no protection, any legal action by a PATENT HOLDER on a PENDING patent holder would be most likely seeking IMMEDIATE injunctive relief until settled ie barring all sales, zero dollars revenue until settled.
from 7-11, something is up.
Houston, Texas headquartered Camber Energy Inc.'s shares closed the day 32.45% higher at $0.32 . The stock recorded a trading volume of 5.81 million shares, which was higher than its three months average volume of 747,660 shares. The Company's shares have surged 56.23% in the last month. The stock is trading 35.72% above its 50-day moving average. Additionally, shares of Camber Energy , which engages in the exploitation, development, and production of crude oil, natural gas, and natural gas liquids in Texas and Oklahoma, have an RSI of 67.12.
Total crude oil and natural gas revenues for the year ended March 31, 2017 increased $4.3 million, or 448%, to $5.3 million compared to $1.0 million for the same period a year ago due primarily to a favorable production volume variance as a result of the Acquisition and our joint drilling program with Lonestar Resources entered into in August 2016.
They have 33 billion dollars net after its produced in production reserves oil ng and gas, and another 23 billion dollars net in proven not yet developed oil ng and gas.
CEO has been buying his own stock 2017.
They are a small producer squatting on large reserves. Possible sale of some of the reserves to COMSTOCK to offset debts and continue operations has been touted by some today.
SP today opened up 35 dropped and ah went back to 35.
By the way, TUTES?
Look at that data, they all were SELLING then on 4-21 cytr announces ASCO. look at that data, all the tutes BOUGHT right after that announcement, fell for it just like we did lol.
https://fintel.io/so/us/cytr
Well, a lot of tutes sold off, and we dont know how many are going to hold now that there will be no r/s and delisting that is more real.
https://fintel.io/so/us/cytr
tutes gamble too and this was a bargain basement gamble for them when you look at their purchase date. Dont know how many of them bought POST ASCO either. Or sold off post asco.
The SH will hate me but....
If this DRUG was any good, then it would have FLOWN and SOARED when presented at ASCO to the EXPERTS gathered there, and the issue of a r/s would be nonexistent.
No one is going to convince me that they brought THE CURE, THE HOLY GRAIL to a gathering of THOUSANDS of experts in the field and they DIDN'T GET IT but the stockholders do.
I cant stand AF but he may be 100% correct on this. Has the company become all about survival at any cost with no true pipeline ? I don't know, but they haven't convinced me that they have a pipeline.
I think their presentation of the SCLC data will be very interesting. If they ever present it, at the SH meeting they said it was CONFIDENTIAL, What ?
I used to own this, sold it. I wont own it again. GLTA that do, wish u well. Personally, everything I have DD, including the PAID PUMPING by CYTR investigated by the SEC, yeah, umm no.
is trading this just like trading a stock or are there fees and such or any gotchas to trading it